Weekly Docetaxel, Cisplatin, and Cetuximab in Palliative Treatment of Patients with Squamous Cell Carcinoma of the Head and Neck

LESSONS LEARNED. Chemotherapy for recurrent, metastatic squamous cell carcinoma of the head and neck need not be known for extreme toxicity. The weekly regimen studied here has been demonstrated to be tolerable and effective. BACKGROUND. The objective of this study was to establish the response rate...

Descripción completa

Detalles Bibliográficos
Autores principales: Trieu, Vanessa, Pinto, Harlan, Riess, Jonathan W., Lira, Ruth, Luciano, Richard, Coty, Jessie, Boothroyd, Derek, Colevas, A. Dimitrios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2018
Materias:
Clinical Trial Results
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058339/
https://www.ncbi.nlm.nih.gov/pubmed/29540603
http://dx.doi.org/10.1634/theoncologist.2017-0618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058339/
https://www.ncbi.nlm.nih.gov/pubmed/29540603
http://dx.doi.org/10.1634/theoncologist.2017-0618

Ejemplares similares